Veterinary Medicine Information website

CANIGEN CHPPI/LR

Authorised
  • Rabies virus, strain VP12, Inactivated
  • Canine adenovirus 2, strain Manhattan, Live
  • Canine distemper virus, strain Lederle, Live
  • Canine parvovirus, strain Cornell 780916, Live
  • Canine parainfluenza virus, strain Manhattan, Live
  • Leptospira interrogans, serovar Canicola, strain 601903, Inactivated
  • Leptospira interrogans, serovar Icterohaemorrhagiae, strain 601895, Inactivated
Download as PDF

Product identification

Medicine name:
CANIGEN CHPPI/LR
Active substance:
  • Rabies virus, strain VP12, Inactivated
  • Canine adenovirus 2, strain Manhattan, Live
  • Canine distemper virus, strain Lederle, Live
  • Canine parvovirus, strain Cornell 780916, Live
  • Canine parainfluenza virus, strain Manhattan, Live
  • Leptospira interrogans, serovar Canicola, strain 601903, Inactivated
  • Leptospira interrogans, serovar Icterohaemorrhagiae, strain 601895, Inactivated
Target species:
  • Dog
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Rabies virus, strain VP12, Inactivated
    1.00
    international unit(s)
    /
    1.00
    Dose
  • Canine adenovirus 2, strain Manhattan, Live
    4.00
    log10 50% tissue culture infectious dose
    /
    1.00
    Dose
  • Canine distemper virus, strain Lederle, Live
    3.00
    log10 50% tissue culture infectious dose
    /
    1.00
    Dose
  • Canine parvovirus, strain Cornell 780916, Live
    5.00
    log10 50% tissue culture infectious dose
    /
    1.00
    Dose
  • Canine parainfluenza virus, strain Manhattan, Live
    5.00
    log10 50% tissue culture infectious dose
    /
    1.00
    Dose
  • Leptospira interrogans, serovar Canicola, strain 601903, Inactivated
    1.00
    Hamster protective Dose 80%
    /
    1.00
    Dose
  • Leptospira interrogans, serovar Icterohaemorrhagiae, strain 601895, Inactivated
    1.00
    Hamster protective Dose 80%
    /
    1.00
    Dose
Pharmaceutical form:
  • Lyophilisate and suspension for suspension for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI07AJ06
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • France
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
  • Virbac
Marketing authorisation date:
Manufacturing sites for batch release:
  • Virbac
Responsible authority:
  • French Agency For Food, Environmental And Occupational Health & Safety
Authorisation number:
  • FR/V/9537234 7/1990
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 7/02/2025
Download

Package Leaflet and Labelling

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 15/10/2025
Download